This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2020 Oct 1;180(10):1362.

doi: 10.1001/jamainternmed.2020.4624.

Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers

Mitchell H Katz^{1

2}

Affiliations

PMID: 32808969
DOI: 10.1001/jamainternmed.2020.4624

Comment

Neutralizing Antibodies Against SARS-CoV-2-Important Questions, Unclear Answers

Mitchell H Katz. JAMA Intern Med. 2020.

. 2020 Oct 1;180(10):1362.

doi: 10.1001/jamainternmed.2020.4624.

Author

Mitchell H Katz^{1

2}

Affiliations

¹ NYC Health + Hospitals, New York, New York.
² Deputy Editor, JAMA Internal Medicine.

PMID: 32808969
DOI: 10.1001/jamainternmed.2020.4624

No abstract available

PubMed Disclaimer

Comment on

Evaluating the Association of Clinical Characteristics With Neutralizing Antibody Levels in Patients Who Have Recovered From Mild COVID-19 in Shanghai, China.
Wu F, Liu M, Wang A, Lu L, Wang Q, Gu C, Chen J, Wu Y, Xia S, Ling Y, Zhang Y, Xun J, Zhang R, Xie Y, Jiang S, Zhu T, Lu H, Wen Y, Huang J. Wu F, et al. JAMA Intern Med. 2020 Oct 1;180(10):1356-1362. doi: 10.1001/jamainternmed.2020.4616. JAMA Intern Med. 2020. PMID: 32808970 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Miscellaneous
- NCI CPTAC Assay Portal